diacerein has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharti, R; Dey, G; Jaganathan, SK; Mandal, M; Ojha, PK; Rajput, S; Sen, R | 1 |
| Banerjee, I; Bharti, R; Das, CK; Das, SK; Dey, G; Dey, KK; Emdad, L; Fisher, PB; Kumar, BN; Mandal, M; Misra, M; Mukherjee, M; Pal, I; Parida, S; Pradhan, AK | 1 |
2 other study(ies) available for diacerein and Breast Cancer
| Article | Year |
|---|---|
Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer.
Topics: Active Transport, Cell Nucleus; Anthraquinones; Anti-Inflammatory Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Interleukin-6; Phosphorylation; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2016 |
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Breast Neoplasms; Female; Humans; Interleukin-6; Liposomes; Mice; Mice, Nude; Receptors, Somatostatin | 2017 |